Cancer and ageing: rival demons?
The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
Organisms with renewable tissues use a network of genetic pathways and cellular responses to prevent cancer. The main mammalian tumour-suppressor pathways evolved from ancient mechanisms that, in simple post-mitotic organisms, act predominantly to regulate embryogenesis or to protect the germline. The shift from developmental and/or germline maintenance in simple organisms to somatic maintenance in complex organisms might have evolved at a cost. Recent evidence indicates that some mammalian tumour-suppressor mechanisms contribute to ageing. How might this have happened, and what are its implications for our ability to control cancer and ageing?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several lines of evidence indicate that cellular senescence is a potent tumor-suppressive mechanism [ 4 , 9 , 10 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“Despite support for the idea that senescence is a beneficial anticancer mechanism, indirect evidence suggests that senescent cells can also be deleterious and might contribute to age-related pathologies [ 10 , 23 – 25 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“It is a cellular program which acts as a double-edged sword, with both beneficial and detrimental effects on the health of the organism, and considered to be an example of evolutionary antagonistic pleiotropy.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Campisi, 2003
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524 · cited 1×
“Apoptosis and ageing How might apoptosis contribute to ageing? In the somatic tissues of adult complex organisms, apoptosis is important for maintaining tissue homeostasis; defective apoptosis (either too little or too much) is associated with a number of disease”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Research works printed but not linked: 2
- Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112–126 (1999). · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- Davenport, J. Tumor-free but not in the clear. Science, SAGE–KE, 2002.
Cited by
Items 501–511 of 511
He, D., Liu, L., Zhang, Z., Yang, X., Jia, Y., Wen, Y., Cheng, S., Meng, P., Li, C., Zhang, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22598750
He, D., Liu, L., Zhang, Z., Yang, X., Jia, Y., Wen, Y., Cheng, S., Meng, P., Li, C., Zhang, H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22598741
Kahli, M. (2011) · theses.fr (ABES) · doi:10.70675/bc7bcb93z46bdz473aza3ebz5cc713b77897 · Cited by 1
Roles of the multifunctional protein E4F1 in cellular senescence
Maciejewska, Z. (2010) · theses.fr (ABES) · doi:10.70675/21f99f8bze775z413fza364z48dd293ca460
Ferdousi, L. V. (2014) · theses.fr (ABES) · doi:10.70675/9d73199ez7949z4602zadcfz6763e4bdd1b0
Jacqueline, C. M. (2017) · theses.fr (ABES) · doi:10.70675/d539649bz1298z4794zab28z3d5d7540c85f
How Somatic Mutations cause Aging without Causing AgingPreprint
Wolf, A. M. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6431458
Shvedova, M. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1776669
“…plays beneficial roles during development and regeneration (Shvedova et al., 2022), chronic accumulation of senescent cells contributes to aging-associated diseases and even increases cancer risk later in life (Vijg, 2021; Vijg, 2014; Campisi, 2003a; Campisi, 2003b; Gems and Kern, 2022).”
Genetic architecture of lipoma susceptibility implicates telomere biologyPreprint
Lowry, D. B. (2026) · medRxiv · doi:10.64898/2026.09.08.26362503
Metadata
- Authors
- Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Nature Reviews Cancer
- Published
- 2003-05
- Volume
- 3
- Issue
- 5
- Pages
- 339-349
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2096846805
- Cited by
- 512
- References
- 158
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 12 · 2022: 14 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 23 · 2014: 20 · 2013: 19 · 2012: 23
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cancer, aging, tumor suppressor pathways, somatic maintenance, embryonic development
- MeSH terms
- Aging, DNA Repair, Humans, Longevity, Neoplasms, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cellular Senescence, Apoptosis, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.